These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9082652

  • 21. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC, Harrer MD, Kuenzle S, Meier M, Goebels N.
    Eur J Immunol; 2008 Jul; 38(7):2014-23. PubMed ID: 18521957
    [Abstract] [Full Text] [Related]

  • 22. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 23. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G, Banati R.
    Brain Res Brain Res Rev; 2004 Nov; 46(3):261-81. PubMed ID: 15571769
    [Abstract] [Full Text] [Related]

  • 24. Enhanced microglial clearance of myelin debris in T cell-infiltrated central nervous system.
    Nielsen HH, Ladeby R, Fenger C, Toft-Hansen H, Babcock AA, Owens T, Finsen B.
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):845-56. PubMed ID: 19606068
    [Abstract] [Full Text] [Related]

  • 25. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 2009 Aug; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 26. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K, Bitsch A, Bunkowski S, Hemmerlein B, Brück W.
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [Abstract] [Full Text] [Related]

  • 27. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E.
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [Abstract] [Full Text] [Related]

  • 28. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN, Snyder DS.
    CRC Crit Rev Clin Neurobiol; 1984 Jan; 1(1):45-82. PubMed ID: 6400508
    [Abstract] [Full Text] [Related]

  • 29. [The pathogenesis of multiple sclerosis. Cytotoxic antibodies against myelin sheath tissue in multiple sclerosis].
    Frick E, Stickl H.
    Fortschr Med; 1976 Jun 10; 94(17):1019-24. PubMed ID: 964856
    [Abstract] [Full Text] [Related]

  • 30. Multiple sclerosis. Presenting an odd autoantigen.
    Steinman L.
    Nature; 1995 Jun 29; 375(6534):739-40. PubMed ID: 7541112
    [No Abstract] [Full Text] [Related]

  • 31. [Immunology for understanding the pathogenesis of multiple sclerosis].
    Matsui M.
    Rinsho Shinkeigaku; 2013 Jun 29; 53(11):898-901. PubMed ID: 24291827
    [Abstract] [Full Text] [Related]

  • 32. The pathology of multiple sclerosis.
    Sobel RA.
    Neurol Clin; 1995 Feb 29; 13(1):1-21. PubMed ID: 7739499
    [Abstract] [Full Text] [Related]

  • 33. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
    Schirmer L, Srivastava R, Hemmer B.
    Mult Scler; 2014 Mar 29; 20(3):271-9. PubMed ID: 24589684
    [Abstract] [Full Text] [Related]

  • 34. The role of immune system cells in multiple sclerosis.
    Compr Ther; 1990 Dec 29; 16(12):67. PubMed ID: 2076604
    [No Abstract] [Full Text] [Related]

  • 35. Absence of cross-reactive antibodies to myelin and viral antigens in multiple sclerosis.
    Bernard CC, Townsend E.
    Prog Clin Biol Res; 1984 Dec 29; 146():215-22. PubMed ID: 6201892
    [No Abstract] [Full Text] [Related]

  • 36. Notes on the pathogenesis of multiple sclerosis.
    Poser CM.
    Clin Neurosci; 1994 Dec 29; 2(3-4):258-65. PubMed ID: 7749896
    [Abstract] [Full Text] [Related]

  • 37. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes.
    Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, Desbois S, Waisman A, Lassmann H, Liblau RS, Mars LT.
    J Immunol; 2008 Aug 01; 181(3):1617-21. PubMed ID: 18641296
    [Abstract] [Full Text] [Related]

  • 38. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S, Dumas M.
    Neurol Clin; 1983 Aug 01; 1(3):729-55. PubMed ID: 6680171
    [Abstract] [Full Text] [Related]

  • 39. Limiting and repairing the damage in multiple sclerosis.
    Compston A.
    Schweiz Med Wochenschr; 1993 Jun 05; 123(22):1145-52. PubMed ID: 8322049
    [Abstract] [Full Text] [Related]

  • 40. Multiple sclerosis as a disease of immune regulation.
    Waksman BH, Reynolds WE.
    Proc Soc Exp Biol Med; 1984 Mar 05; 175(3):282-94. PubMed ID: 6229799
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.